Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of a New Imagingtechnologie for Thrombosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with AAA (diameter \>3.5cm in duplex sonography) or acute DVT.~* Male and female patients 18 years and older,~* Signed Informed Consent after being informed~Exclusion Criteria:~* contraindications to the class of drugs under study, e.g. known hypersensitivity or allergy to class of drugs or the investigational product,~* women who are pregnant or breast feeding,~* women with the intention to become pregnant during the course of the study,~* other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease),~* renal clearance \< 30 mL/min~* known or suspected non-compliance, drug or alcohol abuse,~* inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the subject,~* participation in another study with an investigational drug during the present study and 7 days thereafter.~* enrolment of the investigator, his family members, employees and other dependent persons~* last systemic treatment with GP IIb/IIIa antagonists should not have been applied within 48 h before performing study exam

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnosis with GP1 (Type: EXPERIMENTAL): Injection and scanning of \[18F\]-GP1

Based on this trial design, predict the completion outcome and termination type (if applicable).